Home / Mirtazapine / Canada
CA ATC N06AX11 · updated 2 Nov 2026
Mirtazapine shortage in Canada
Is there a Mirtazapine shortage in Canada?
Yes. As of 2 Nov 2026, 2 Mirtazapine products are reported short in Canada, the first since 29 May 2023. The company estimate for the return is 24 Nov 2026 (latest 1 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Austria, Belgium, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PMS-MIRTAZAPINE (100) | PHARMASCIENCE INC | 29 May 2023 | 1 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-MIRTAZAPINE (100BT) | MYLAN PHARMACEUTICALS ULC | 26 Oct 2026 | 24 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.